Risk Factors for Chronic Liver Disease in Blacks, Mexican Americans, and Whites in the United States: Results From NHANES IV, 1999-2004
- 1 September 2008
- journal article
- Published by Wolters Kluwer Health in American Journal of Gastroenterology
- Vol. 103 (9) , 2231-2238
- https://doi.org/10.1111/j.1572-0241.2008.02022.x
Abstract
Morbidity and mortality due to liver disease and cirrhosis vary significantly by race/ethnicity in the United States. We examined the prevalence of liver disease risk factors among blacks, Mexican Americans, and whites, including elevated aspartate aminotransferase and alanine aminotransferase activity, infection with viral hepatitis B or hepatitis C, alcohol intake, obesity, diabetes, and metabolic syndrome. Data were obtained from the Fourth National Health and Nutrition Examination Survey (NHANES IV). A logistic regression was used to examine the association of race/ethnicity to liver disease risk factors, controlling for the demographic and socioeconomic variables. Mexican-American men and women are the most likely to have elevated aminotransferase activity. Among men, Mexican Americans are more likely than whites to be heavy/binge drinkers, and blacks are more likely to have hepatitis B or hepatitis C. Among women, Mexican Americans are more likely than whites to be obese and diabetic, and less likely to be heavy/binge drinkers; blacks are more likely than whites to have hepatitis B or hepatitis C, be obese or diabetic, and less likely to be heavy/binge drinkers. In this national sample, the prevalence of risk factors for liver disease varies by race/ethnicity. Mexican Americans and blacks have a greater risk of developing liver disease than their white counterparts. These findings are consistent with the observed racial/ethnic disparities in morbidity and mortality due to chronic liver disease and contribute to the efforts to identify the causes of these disparities. This information can be used by health professionals to tailor screening and intervention programs.Keywords
This publication has 30 references indexed in Scilit:
- Alanine aminotransferase as a marker of non‐alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular diseaseDiabetes/Metabolism Research and Reviews, 2006
- Nonalcoholic Fatty Liver Disease: From Steatosis to CirrhosisHepatology, 2006
- Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of EthnicityHepatology, 2004
- Comparison of Hepatocellular Carcinoma Patients With Alcoholic Liver Disease and Nonalcoholic SteatohepatitisAlcohol, Clinical and Experimental Research, 2004
- Non‐alcoholic steatohepatitis in type 2 diabetes mellitusJournal of Gastroenterology and Hepatology, 2004
- Primary prevention of cirrhosisPostgraduate Medicine, 2004
- The Critical Dimension of Ethnicity in Liver Cirrhosis Mortality StatisticsAlcohol, Clinical and Experimental Research, 2001
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Evaluation of Abnormal Liver-Enzyme Results in Asymptomatic PatientsNew England Journal of Medicine, 2000
- Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity☆, ☆☆Gastroenterology, 1999